secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001021771-24-000158
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative Therapies schedules Q2 2024 earnings release and call for Aug 13
-------------------------------------------------------------------------------

- Financial results for Q2 2024 will be released after market close on Tuesday, August 13, 2024.
- Management will host a conference call following the release to review results and provide a business update.
- Press release announcing the schedule was issued on August 6, 2024.
- No financial figures or guidance were provided in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177124000158/0001021771-24-000158-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177124000158/brt8624.htm
  HTML page:      https://secwatch.observer/filing/0001021771-24-000158

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer